Statement of Principles concerning Morton metatarsalgia (Balance of Probabilities) (No. 78 of 2019)

Administered by Department of Veterans' Affairs

Legislation au F2019L01100 In force Legislative Instrument

Legislation content

EXPLANATORY STATEMENT

 

STATEMENT OF PRINCIPLES CONCERNING

MORTON METATARSALGIA

(BALANCE OF PROBABILITIES) (NO. 78 OF 2019)

 

VETERANS' ENTITLEMENTS ACT 1986

MILITARY REHABILITATION AND COMPENSATION ACT 2004

 

  1. This is the Explanatory Statement to the Statement of Principles concerning Morton metatarsalgia (Balance of Probabilities) (No. 78 of 2019).

Background

2.             The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans' Entitlements Act 1986 (the VEA), repeals Instrument No. 93 of 2010 (Federal Register of Legislation No. F2010L02849) determined under subsection 196B(3) of the VEA concerning Morton's metatarsalgia.

3.             The Authority is of the view that on the sound medical-scientific evidence available it is more probable than not that Morton metatarsalgia and death from Morton metatarsalgia can be related to particular kinds of service.  The Authority has therefore determined pursuant to subsection 196B(3) of the VEA a Statement of Principles concerning Morton metatarsalgia (Balance of Probabilities) (No. 78 of 2019).  This Instrument will in effect replace the repealed Statement of Principles.

Purpose and Operation

4.             The Statement of Principles will be applied in determining claims under the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).

5.             The Statement of Principles sets out the factors that must exist, and which of those factors must be related to the following kinds of service rendered by a person:

 eligible war service (other than operational service) under the VEA;

 defence service (other than hazardous service and British nuclear test defence service) under the VEA;

 peacetime service under the MRCA,

before it can be said that, on the balance of probabilities, Morton metatarsalgia or death from Morton metatarsalgia is connected with the circumstances of that service.  The Statement of Principles has been determined for the purposes of both the VEA and the MRCA.

6.             This Instrument results from an investigation notified by the Authority in the Government Notices Gazette of 8 May 2018 concerning Morton's metatarsalgia in accordance with section 196G of the VEA.  The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.

7.             The contents of this Instrument are in similar terms as the repealed Instrument.  Comparing this Instrument and the repealed Instrument, the differences include:

  • adopting the latest revised Instrument format, which commenced in 2015;
  • specifying a day of commencement for the Instrument in section 2;
  • changing the name of the condition from 'Morton's metatarsalgia' to 'Morton metatarsalgia' to accord with contemporary medical nomenclature;
  • revising the definition of 'Morton metatarsalgia' in subsection 7(2);
  • revising the reference to ICD-10-AM code in subsection 7(4);
  • revising the factors in subsections 9(1) and 9(6) concerning footwear;
  • revising the factors in subsections 9(4) and 9(9) concerning deformity of the affected foot;
  • revising the factors in subsections 9(5) and 9(10) concerning inflammatory arthritis;
  • new definitions of 'MRCA', 'specified list of deformities of the foot' and 'VEA' in Schedule 1 – Dictionary;
  • revising the definition of 'relevant service' in the Schedule 1 – Dictionary; and
  • deleting the definitions of 'a biomechanical abnormality' and 'a condition as specified' in Schedule 1 – Dictionary.

Consultation

8.             Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to Morton's metatarsalgia in the Government Notices Gazette of 8 May 2018, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants.  The Authority invited submissions from the Repatriation Commission, the Military Rehabilitation and Compensation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field.  No submissions were received for consideration by the Authority during the investigation.

Human Rights

9.             This instrument is compatible with the Human Rights and Freedoms recognised or declared in the International Instruments listed in Section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.  A Statement of Compatibility with Human Rights follows.

Finalisation of Investigation

10.         The determining of this Instrument finalises the investigation in relation to Morton's metatarsalgia as advertised in the Government Notices Gazette of 8 May 2018.

References

11.         A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA.  Any such request must be made in writing to the Repatriation Medical Authority at the following address:

The Registrar

Repatriation Medical Authority

GPO Box 1014

BRISBANE    QLD    4001

Statement of Compatibility with Human Rights

(Prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011)

 

Instrument No.:   Statement of Principles No. 78 of 2019

Kind of Injury, Disease or Death: Morton metatarsalgia

 

This Legislative Instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Overview of the Legislative Instrument

1. This Legislative Instrument is determined pursuant to subsection 196B(3) of the Veterans' Entitlements Act 1986 (the VEA) for the purposes of the VEA and the Military Rehabilitation and Compensation Act 2004 (the MRCA).  Part XIA of the VEA requires the determination of these instruments outlining the factors connecting particular kinds of injury, disease or death with service such being determined solely on the available sound medical-scientific evidence.

2. This Legislative Instrument:-

  • facilitates claimants in making, and the Repatriation Commission in assessing, claims under the VEA and the MRCA respectively, by specifying the circumstances in which medical treatment and compensation can be extended to eligible persons who have Morton metatarsalgia;
  • facilitates the review of such decisions by the Veterans' Review Board and the Administrative Appeals Tribunal;
  • outlines the factors which the current sound medical-scientific evidence indicates must exist before it can be said that, on the balance of probabilities, Morton metatarsalgia is connected with the circumstances of eligible service rendered by a person, as set out in clause 5 of the Explanatory Statement;
  • replaces Instrument No. 93 of 2010; and
  • reflects developments in the available sound medical-scientific evidence concerning Morton metatarsalgia which have occurred since that earlier instrument was determined. 

3. The Instrument is assessed as being a technical instrument which improves the medico-scientific quality of outcomes under the VEA and the MRCA.   

Human Rights Implications

4. This Legislative Instrument does not derogate from any human rights. It promotes the human rights of veterans, current and former Defence Force members as well as other persons such as their dependents, including:

  • the right to social security (Art 9, International Covenant on Economic, Social and Cultural Rights; Art 26, Convention on the Rights of the Child and Art 28, Convention on the Rights of Persons with Disabilities) by helping to ensure that the qualifying conditions for the benefit are 'reasonable, proportionate and transparent'[1];
  • the right to an adequate standard of living (Art 11, ICSECR; Art 27, CRC and Art 28, CRPD) by facilitating the assessment and determination of social security benefits;
  • the right to the enjoyment of the highest attainable standard of physical and mental health (Art 12, ICSECR and Art 25, CRPD), by facilitating the assessment and determination of compensation and benefits in relation to the treatment and rehabilitation of veterans and Defence Force members;
  • the rights of persons with disabilities by facilitating the determination of claims relating to treatment and rehabilitation (Art 26, CRPD); and
  • ensuring that those rights "will be exercised without discrimination of any kind as to race, colour, sex, language, religion, political or other opinion, national or social origin, property, birth or other status" (Art 2, ICESCR).

Conclusion

This Legislative Instrument is compatible with human rights as it does not derogate from and promotes a number of human rights.

 

Repatriation Medical Authority

 

 

 

 

 

 

[1] In General Comment No. 19 (The right to social security), the Committee on Economic, Social and Cultural Rights said (at paragraph 24) this to be one of the elements of ensuring accessibility to social security.

Overview

The Statement of Principles concerning Morton metatarsalgia (Balance of Probabilities) (No. 78 of 2019) was enacted in 2019 and is an instrument under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). This legislative instrument was introduced to address the need for updated medical evidence and a revised framework for determining the connection between Morton metatarsalgia and particular kinds of service. The Repatriation Medical Authority, operating under the VEA, repealed the previous Instrument No. 93 of 2010 and determined this new statement of principles based on the sound medical-scientific evidence available. The policy objective is to facilitate the assessment and determination of claims related to Morton metatarsalgia, ensuring that eligible veterans and service personnel can access appropriate compensation and medical treatment. The new instrument also aims to reflect contemporary medical nomenclature and the latest medical-scientific evidence concerning Morton metatarsalgia.

Scope and Application

The Statement of Principles concerning Morton metatarsalgia (Balance of Probabilities) (No. 78 of 2019) applies to veterans and current or former members of the Defence Force who are seeking compensation or medical treatment for Morton metatarsalgia under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). This Instrument specifies the circumstances in which a claimant can assert a connection between their Morton metatarsalgia and their service, facilitating both the assessment of claims by the Repatriation Commission and the review of decisions by the Veterans' Review Board and the Administrative Appeals Tribunal. The Instrument outlines the medical and service-related factors that must exist for a claimant to establish, on the balance of probabilities, that their Morton metatarsalgia is connected with their service. It applies to Commonwealth jurisdiction and replaces the previously repealed Instrument No. 93 of 2010, reflecting updated medical-scientific evidence. There are no stated exclusions or thresholds within this Instrument, but its application may be extended or restricted through subordinate instruments under the VEA and MRCA.

Key Provisions

The Statement of Principles concerning Morton metatarsalgia (Balance of Probabilities) (No. 78 of 2019) is a legislative instrument determined by the Repatriation Medical Authority under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004 (MRCA). This instrument sets out the medical factors that must exist for it to be said that, on the balance of probabilities, Morton metatarsalgia is connected with the circumstances of eligible service (sections 4 and 5). It specifies the kinds of service for which claims can be made under the VEA and the MRCA and outlines the relevant medical evidence and factors necessary to support a claim. The instrument has replaced the previous Statement of Principles No. 93 of 2010, reflecting the latest medical-scientific evidence. The obligations imposed by this Act include the requirement for claimants to provide evidence that their Morton metatarsalgia is connected to their service, in accordance with the specified medical factors and conditions. The Repatriation Medical Authority must assess the claims based on the sound medical-scientific evidence available and determine the connection between the service and the condition as outlined in the Statement of Principles. The Repatriation Commission and the Military Rehabilitation and Compensation Commission are responsible for administering the claims and benefits under the VEA and MRCA, respectively, following the guidelines provided by this instrument. Breaches of the obligations outlined in the Statement of Principles could result in the denial of claims for compensation and medical treatment. While the legislation does not explicitly state penalties for non-compliance, it is likely that any misrepresentation of facts or fraudulent claims could be subject to the general legal consequences applicable to fraud and misrepresentation under Australian law. Additionally, any party found to be in breach of the obligations may face legal challenges and disputes, potentially leading to civil or administrative penalties if found liable for misrepresentation or failure to comply with the requirements of the VEA and MRCA.

Legal classification tags

Area of Law
Veterans' Law
Instrument
Regulation
Concepts
Definitions & Interpretation
Licensing & Registration
Compliance Obligations
Human Rights Law
Catchwords
Morton metatarsalgia

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.